AVIDITY BIOSCIENCES, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 40.79 USD | +0.07% |
|
-0.49% | +350.72% |
| Aug. 28 | Barclays Initiates Avidity Biosciences at Overweight | MT |
| Aug. 26 | Evercore ISI Trims Price Target on Avidity Biosciences to $53 From $54, Keeps Outperform Rating | MT |
Chart calendar Avidity Biosciences, Inc.
4e9834a4771.qnL0SX5HExMXL_ajNYGl-tg0nXxzMqB7V7qH2IrJdmM.7USECAkjUV17f7_AALPElbp98ToBQ8pIYenqoNP-MizkF8IfHB9aYHZ3sw~b5a8256c41bfa3203bed8539af9025ac
Upcoming events on Avidity Biosciences, Inc.
Past events on Avidity Biosciences, Inc.
| 2024-09-04 08:00 am | Wells Fargo Healthcare Conference |
| 2024-08-09 04:05 pm | Q2 2024 Earnings Release |
| 2024-08-09 08:00 am | Business Update Call |
| 2024-06-20 01:00 pm | Business Update Call |
| 2024-06-20 11:20 am | TD Cowen Genetic Medicines & RNA Summit |
| 2024-06-14 06:50 pm | FSHD Society International Research Congress |
| 2024-06-13 12:00 pm | Annual General Meeting |
| 2024-06-13 09:00 am | FSHD Society International Research Congress |
| 2024-06-12 08:00 am | Investor and Analyst Meeting |
| 2024-05-15 11:00 am | BofA Securities Health Care Conference |
| 2024-05-09 04:05 pm | Q1 2024 Earnings Release |
| 2024-04-10 02:15 pm | Needham Healthcare Conference |
| 2024-04-03 12:40 pm | Cantor Fitzgerald Muscular Dystrophy Symposium |
| 2024-03-13 01:05 pm | Barclays Global Healthcare Conference |
| 2024-03-12 03:00 pm | Leerink Partners Global Biopharma Conference |
| 2024-03-05 06:00 pm | Muscular Dystrophy Association Clinical & Scientific Conference - AOC 1001 |
| 2024-03-05 01:30 pm | TD Cowen Health Care Conference |
| 2024-03-04 06:00 pm | Muscular Dystrophy Association Clinical & Scientific Conference - AOC 1044 |
| 2024-03-04 08:00 am | Muscular Dystrophy Association Clinical & Scientific Conference |
| 2024-02-28 04:05 pm | Q4 2023 Earnings Release |
Annual results
| Fiscal Period | December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 9,33 9,53 -2.09% | 9,22 8,33 10.75% | 9,56 19,6 -51.18% | 13,3 | 11,9 | 71,2 |
|
EBITDA Million USD | Released Forecast Spread | -117 -115 -2.1% | -178 -182 2.48% | -233 -229 -1.79% | -319 | -339 | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -118 -112 -5.69% | -179 -176 -1.64% | -236 -215 -9.38% | -327 | -360 | -368 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -118 -112 -5.62% | -174 -174 -0.24% | -212 -195 -8.63% | -295 | -346 | -347 |
|
Net income Million USD | Released Forecast Spread | -118 -112 -5.23% | -174 -173 -0.32% | -212 -200 -6.21% | -299 | -346 | -370 |
|
EPS USD | Released Forecast Spread | -2,85 -2,73 -4.59% | -3,34 -3,35 0.43% | -2,91 -2,76 -5.43% | -2,92 | -3,07 | -3,19 |
| Announcement Date | 01/03/22 | 28/02/23 | 28/02/24 | - |
Quarterly results
| Fiscal Period | Juni | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 2,48 2,15 15.67% | 2,77 1,88 47.68% | 2,23 1,75 27.41% | 2,32 1,89 22.82% | 2,82 1,84 52.76% | 2,19 12,2 -82.04% | 3,54 2,57 37.85% | 2,05 3,01 -32.13% | 4,94 | 2,80 | 4,03 | 4,03 | 4,03 | 4,03 |
|
EBITDA Million USD | Released Forecast Spread | -76,5 -64,6 -18.4% | -81,9 -60,8 -34.86% | -80,9 | -80,8 | ||||||||||
|
EBIT Million USD | Released Forecast Spread | -44,9 -48,4 7.16% | -53,2 -50,3 -5.75% | -57,6 -54,8 -5.13% | -52,6 -59,0 10.84% | -58,6 -59,6 1.57% | -66,7 -46,5 -43.54% | -77,2 -67,4 -14.49% | -82,6 -74,5 -10.91% | -80,6 | -86,4 | -72,6 | -73,3 | -74,2 | -75,0 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -43,6 -47,6 8.42% | -50,5 -48,2 -4.7% | -52,4 -55,5 5.66% | -47,0 -58,2 19.15% | -52,4 -55,2 5.15% | -60,4 -43,6 -38.72% | -68,9 -64,5 -6.7% | -70,8 -74,6 5.06% | -72,2 | -79,6 | -59,4 | -60,4 | -61,8 | -63,1 |
|
Net income Million USD | Released Forecast Spread | -43,6 -48,3 9.79% | -50,5 -48,4 -4.22% | -52,4 -56,2 6.82% | -47,0 -58,4 19.45% | -52,4 -55,7 6.04% | -60,4 -48,0 -25.82% | -68,9 -65,5 -5.19% | -70,8 -72,6 2.49% | -75,8 | -81,3 | -77,2 | -78,6 | -80,3 | -82,0 |
|
EPS USD | Released Forecast Spread | -0,82 -0,93 12.1% | -0,88 -0,89 0.8% | -0,74 -0,85 12.94% | -0,66 -0,80 17.35% | -0,71 -0,76 6.17% | -0,79 -0,66 -19.7% | -0,79 -0,87 8.67% | -0,65 -0,79 17.85% | -0,72 | -0,78 | -0,74 | -0,74 | -0,78 | -0,79 |
| Announcement Date | 08/11/22 | 28/02/23 | 09/05/23 | 08/08/23 | 08/11/23 | 28/02/24 | 09/05/24 | 09/08/24 | - | - | - | - | - | - |
More events
Past sector events for Avidity Biosciences, Inc.
| 2024-09-09 04:05 pm | AVID BIOSERVICES, INC.: Q1 2025 Earnings Release |
| 2024-09-05 06:30 am | KALVISTA PHARMACEUTICALS, INC.: Q1 2025 Earnings Release |
| 2024-08-30 11:56 pm | SHANGHAI JUNSHI BIOSCIENCES CO., LTD.: Q2 2024 Earnings Release |
| 2024-08-30 | TONGHUA DONGBAO PHARMACEUTICAL CO., LTD.: Q2 2024 Earnings Release |
| 2024-08-29 | CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.: Q2 2024 Earnings Release |
| 2024-08-29 | BEIJING BOHUI INNOVATION BIOTECHNOLOGY GROUP CO., LTD.: Q2 2024 Earnings Release |
| 2024-08-29 | HUALAN BIOLOGICAL VACCINE INC.: Q2 2024 Earnings Release |
| 2024-08-29 | HUALAN BIOLOGICAL ENGINEERING INC.: Q2 2024 Earnings Release |
| 2024-08-29 07:32 am | CLINUVEL PHARMACEUTICALS LIMITED: Q4 2024 Earnings Release |
| 2024-08-28 | AIM VACCINE CO., LTD.: Q2 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- RNA Stock
- Calendar Avidity Biosciences, Inc.